Weight loss specialist Laura Alexis at Health Solutions and Weightloss wants to help you take control of your health by jump ...

A new study from CSIRO, Australia's national science agency, has revealed that people who use meal plans lose more weight, ...

Losing weight is a top New Year’s resolution. But this year, doctors might prescribe more than just diet and exercise.

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.

CMS has launched the BALANCE Model, a five-year test to lower costs & expand Medicare access to GLP-1 weight-loss drugs while ...

As weight loss journeys increasingly play out on social media, a wellness expert is urging caution, noting that dietary needs ...

Calorie deficit and intermittent fasting are weight loss strategies that involve consuming fewer calories in a 24-hour period, but they differ in their focus. Here's how.

The Mazda Miata has always been sold as proof that driving joy is about balance, not brute force, and nowhere is that clearer ...

Industry report addresses OzemPatches ingredient disclosures, transdermal delivery claims, and what ad-exposed consumers ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug. By Gina Kolata Gina Kolata has ...

Eli Lilly on Monday announced new price cuts for its popular weight loss drug Zepbound, broadening access for patients and driving greater use of the company’s digital healthcare platform, LillyDirect ...

Amycretin targets GLP-1 and amylin hormones, seen as potential best-in-class therapy Novo shares rise over 5% after amycretin trial results Amycretin aids significant weight loss and glucose control ...